Alpa Laboratories Ltd.

₹52.2

0.3 (0.6%)

ALPA Share Price

Pharmaceuticals & Biotechnology

As on October 28, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 109.16 Cr

P/E Ratio7.32

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	50.64	Bullish
10-DMA	52.35	Bearish
20-DMA	55.23	Bearish
50-DMA	59.05	Bearish
100-DMA	63.6	Bearish
200-DMA	65.19	Bearish

Historical Performance

1 Year

-41.6%

3 Years

-27.9%

5 Years

3.3%

10 Years

25.9%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	1,058	1,125	1,087	930	1,123
Total Expenditure	1,025	1,077	1,006	849	1,016
Other Income	158	233	149	94	108
Operating Profit	190	281	230	174	214
Interest	3	2	4	2	2
Depreciation	21	22	20	13	17
Profit Before Tax	167	257	207	159	196
Consolidated Net Profit	150	195	168	126	141
Adjusted EPS	7	9	8	6	7

Compounded Sales Growth

10 Years:14.6

5 Years:1.6

3 Years:2.6

TTM:-1.2

Compounded Profit Growth

10 Years:17

5 Years:15.7

3 Years:3.6

TTM:-5.1

Stock Price CAGR

10 Years:2.3

5 Years:0.6

3 Years:-10.3

TTM:-42.7

Return on Equity

10 Years:1.2

5 Years:6.7

3 Years:8

last year:7.1

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	210	210	210	210	210
Total Reserves	1,652	1,511	1,309	1,135	1,007
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	33	45	24	31	47
Other Current Liabilities	258	224	97	109	89
Short Term Borrowings	25	---	45	---	23
Total Liabilities	2,421	2,233	1,824	1,673	1,552
Capital Work in Progress	---	---	---	---	---
Long Term Loans & Advances	6	7	5	14	2
Currents Investments	1,350	1,105	911	720	687
Short Term Loans and Advances	177	134	127	58	95
Total Current Assets	2,109	1,925	1,610	1,491	1,380
Total Assets	2,421	2,233	1,824	1,673	1,552
Adjusted Book Value	89	82	72	64	58

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a low PE of 7.32, which may indicate undervaluation or subdued growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of -10.4%, indicating poor shareholder returns.
The stock carries a beta of 1.0, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹190 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹1058 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 573437.3

No. of Shares: 10985 (Approx)

Performance:-42.7%

-426562.7

NIFTY Performance: -12.9%

1 day Top Gainers